14-105314947-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001100913.3(PACS2):c.29C>T(p.Pro10Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000769 in 1,170,652 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001100913.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PACS2 | NM_001100913.3 | c.29C>T | p.Pro10Leu | missense_variant | 1/25 | ENST00000447393.6 | NP_001094383.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PACS2 | ENST00000447393.6 | c.29C>T | p.Pro10Leu | missense_variant | 1/25 | 1 | NM_001100913.3 | ENSP00000393559.2 |
Frequencies
GnomAD3 genomes AF: 0.0000136 AC: 2AN: 146656Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000153 AC: 1AN: 65388Hom.: 0 AF XY: 0.0000259 AC XY: 1AN XY: 38626
GnomAD4 exome AF: 0.00000684 AC: 7AN: 1023996Hom.: 0 Cov.: 20 AF XY: 0.00000400 AC XY: 2AN XY: 500462
GnomAD4 genome AF: 0.0000136 AC: 2AN: 146656Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 71362
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 15, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with PACS2-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.004%). This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 10 of the PACS2 protein (p.Pro10Leu). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at